Saquinavir (Fortovase, Invirase): News
- Roche to Discontinue Production of Nelfinavir and Saquinavir 200-mg Hard Capsules (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Changes to Starting Dose of Saquinavir in Naive Patients (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Drug Safety Communication: Invirase (Saquinavir) Labels Now Contain Updated Risk Information on Abnormal Heart Rhythms (October 21, 2010)
From U.S. Food and Drug Administration
- New FDA Warning on HIV Drugs Invirase and Norvir (February 24, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Ongoing Safety Review of Invirase (Saquinavir) and Possible Association With Abnormal Heart Rhythms (February 23, 2010)
From U.S. Food and Drug Administration
- Recent Updates to Invirase Package Insert (June 11, 2008)
From U.S. Food and Drug Administration
- Dear Dr. Letter: Fortovase (Saquinavir) Discontinuation Notice (PDF) (May 2005)
From Roche
- Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
To read PDF, click here.
From U.S. Food and Drug Administration
- New 500-mg Tablet Formulation of Invirase (Saquinavir) Approved (December 17, 2004)
From U.S. Food and Drug Administration
- Mama Mia Please Don't Eat the Garlic (Supplements) (February 2002)
In Reasons for Hope, from Search for a Cure
- Ten Texts on Saquinavir: Its Rapid Rise and Fall (PDF) (June 16, 2001)
From Treatment Action Group
- Efavirenz (Sustiva, DMP 266) and Saquinavir (Fortovase) Combination: Pharmacologic Interaction (June 5, 1998)
From AIDS Treatment News
- Correction: Fortovase Information Number for Patients in Washington D.C. Area (December 5, 1997)
In AIDS Treatment News, from AIDS Treatment News
- Fortovase Approved: New Saquinavir Formulation (November 21, 1997)
In AIDS Treatment News, from AIDS Treatment News
- FDA Approves New Formulation of First Protease Inhibitor Saquinavir (November 7, 1997)
From U.S. Food and Drug Administration
- New Saquinavir Formulation: Roche Requests FDA Approval of the Improved "Soft Gel" Capsule (April/May 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
|
Advertisement
|